top of page

Quebec Pancreas Cancer Study

Clinicaltrials.gov ID

NCT04104230

Status

Recruiting

Study Type

Observational

Sponsor

George Zogopoulos

Start Date

March 11, 2012

Anticipated End Date

January 1, 2025

Study Contact

Name: Adeline Cuggia, MSc

Phone Number: 514-934-1934 ext 76333

Email: cancer.pancreas@mcgill.ca

About the Study

The Quebec Pancreas Cancer Study is a prospective clinic-based study consisting of clinical, family history and epidemiologic data, with accompanying biospecimens, from patients diagnosed with either pancreas cancer, a related cancer or a related pre-cancerous condition, and their families.

Conditions

  • Pancreas Cancer

  • Pancreatic Cancer

  • Pancreas Neoplasm

  • Pancreas Cyst

  • Pancreatic Precancerous Condition

  • Familial Pancreatic Cancer

  • Hereditary Cancer

  • Bile Duct Cancer

  • Ampullary Cancer

  • Duodenal Cancer

  • Gallbladder Cancer

Inclusion/Exclusion Criteria?

Primary, Secondary, Other Outcome Measures??

Locations in Canada

  • McGill University Health Centre, Montreal, Quebec, H4A 3J1, Canada

About the Study

The Quebec Pancreas Cancer Study is a prospective clinic-based study consisting of clinical, family history and epidemiologic data, with accompanying biospecimens, from patients diagnosed with either pancreas cancer, a related cancer or a related pre-cancerous condition, and their families.

Conditions

  • Pancreas Cancer

  • Pancreatic Cancer

  • Pancreas Neoplasm

  • Pancreas Cyst

  • Pancreatic Precancerous Condition

  • Familial Pancreatic Cancer

  • Hereditary Cancer

  • Bile Duct Cancer

  • Ampullary Cancer

  • Duodenal Cancer

  • Gallbladder Cancer

Interventions

n/a

Locations in Canada

  • McGill University Health Centre, Montreal, Quebec, H4A 3J1, Canada

  • Instagram
  • Facebook
  • Twitter
image.png
leaf-cihr-colour-en_edited.png

Le Collectif Canadien pour le cholangiocarcinome (C3) est financé par une subvention d'équipe révolutionnaire de la Société Canadienne du cancer en partenariat avec les Instituts de recherche en santé du Canada. Les fonds de la subvention pour le C3 sont gérés par l'Institut de recherche de l'Hôpital d'Ottawa, qui sert d'institut principal pour toutes les opérations collaboratives.

© 2025 www.cholangio.ca. All rights reserved.

bottom of page